Abraham Meizler
Director Ejecutivo en Advantech Bioscience Pharmaceutical Ltd. .
Cargos activos de Abraham Meizler
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Advantech Bioscience Pharmaceutical Ltd. | Director Ejecutivo | 01/01/2010 | - |
| Fundador | 01/01/2010 | - |
Historial de carrera de Abraham Meizler
Antiguos cargos conocidos de Abraham Meizler.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| KADIMASTEM LTD | Director/Miembro de la Junta | 29/04/2014 | 17/12/2020 |
| Meizler UCB Biopharma SA | Presidente | 01/01/2012 | 01/12/2014 |
Meizler Biopharma SA
 Meizler Biopharma SA Pharmaceuticals: MajorHealth Technology Founded in 1990 with the objective of promoting the development of health in Brazil, Meizler Biopharma, 100% national company, specializes in and acquisition of new drugs and existing partnerships with the world's leading pharmaceutical biotech and device doctors. Aimed at public and private institutions, hospitals and clinics, Meizler Biopharma has full-service warehousing and distribution, dynamically structured to meet quickly, increasing government demand for high technology products and affordable prices | Fundador | 01/01/1990 | 01/01/2012 |
| Presidente | 01/01/1990 | 01/01/2012 | |
Raziel Therapeutics RT Ltd.
 Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel. | Director/Miembro de la Junta | - | - |
Atme Comercio E Serviços Ltda.
 Atme Comercio E Serviços Ltda. Real Estate DevelopmentFinance Atme Comercio E Serviços Ltda. is a real estate services company based in Barueri, Brazil. provides real estate services. The Brazilian company was founded by Abraham Meizler. | Fundador | 01/01/2002 | - |
| SCISPARC LTD. | Director/Miembro de la Junta | 09/01/2014 | - |
| Presidente | 21/02/2013 | 09/01/2014 |
Formación de Abraham Meizler.
| Getulio Vargas Foundation | Masters Business Admin |
Estadísticas
Internacional
| Israel | 5 |
| Brasil | 5 |
Operativa
| Director/Board Member | 3 |
| Founder | 3 |
| Chairman | 2 |
Sectorial
| Health Technology | 5 |
| Finance | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| SCISPARC LTD. | Health Technology |
| KADIMASTEM LTD | Health Technology |
| Empresas privadas | 5 |
|---|---|
| Meizler UCB Biopharma SA | |
Meizler Biopharma SA
Meizler Biopharma SA Pharmaceuticals: MajorHealth Technology Founded in 1990 with the objective of promoting the development of health in Brazil, Meizler Biopharma, 100% national company, specializes in and acquisition of new drugs and existing partnerships with the world's leading pharmaceutical biotech and device doctors. Aimed at public and private institutions, hospitals and clinics, Meizler Biopharma has full-service warehousing and distribution, dynamically structured to meet quickly, increasing government demand for high technology products and affordable prices | Health Technology |
| Advantech Bioscience Pharmaceutical Ltd. | |
Atme Comercio E Serviços Ltda.
Atme Comercio E Serviços Ltda. Real Estate DevelopmentFinance Atme Comercio E Serviços Ltda. is a real estate services company based in Barueri, Brazil. provides real estate services. The Brazilian company was founded by Abraham Meizler. | Finance |
Raziel Therapeutics RT Ltd.
Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel. | Health Technology |
- Bolsa de valores
- Insiders
- Abraham Meizler
- Experiencia
